KABIPAC
Fresenius SE
Application Filed: 2010-03-19
Trademark Application Details
ABANDONED - NO STATEMENT OF USE FILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77962974 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Scott D. Woldow |
| Attorney Docket Number | 033716.023 |
| Law Office Assigned | L10 |
| Employee Name | MAYES, LAURIE ANN |
Timeline
| 2010-03-19 | Application Filed |
| 2011-09-27 | Published for Opposition |
| 2012-11-14 | Location: INTENT TO USE SECTION |
| 2014-12-29 | Abandon |
| 2014-12-29 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Fresenius SE |
| Entity Statement | societas europae (se) |
| Address | Else-Kroener-Str. 1 Bad Homburg DE 61352 |
| Legal Entity Type | |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for infusion therapy, namely, infusion solutions for the delivery of drugs and pharmaceutical preparations, namely, for parenteral nutrition and hydration, for use in nutritional therapy, immune therapy, pain therapy, cancer therapy, the treatment of infectious diseases, the treatment of blood and blood volume, the treatment of oedema and for use in anaesthesia, standard infusion solutions for blood volume replacement and drug reconstitution; Pharmaceutical preparations, namely, infusion solutions for prophylaxis and treatment of hypovolemia, namely, macro-circulation and micro-circulation disturbance, for the treatment of therapeutical hemodilution, of acute normovolemic hemodilution and as plasma substitute for blood replacement; Pharmaceutical preparations for infusion therapy for intravenous administration, namely, infusion solutions for the delivery of drugs and pharmaceutical preparations, namely, for parenteral nutrition and hydration, for use in nutritional therapy, immune therapy, pain therapy, cancer therapy, the treatment of infectious diseases, the treatment of blood and blood volume, the treatment of oedema and for use in anaesthesia, standard infusion solutions for blood volume replacement and drug reconstitution, and additives for injection, all sold in prefilled infusion bottles, infusion bags with separate opening points for infusion of those pharmaceutical solutions and for injection of those additives, namely, water for injection, electrolytes, parenteral nutrition and plasma volume expanders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2010-03-23 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2010-03-24 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2010-06-21 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2010-06-21 | 4 CNRT R:Renewal |
| NON-FINAL ACTION MAILED | 2010-06-22 | 5 CNRT F:First Action |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2010-10-27 | 6 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2010-11-16 | 7 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2010-11-16 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2010-11-16 | 9 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2010-12-09 | 10 CNFR R:Renewal |
| FINAL REFUSAL MAILED | 2010-12-10 | 11 CNFR O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2011-05-25 | 12 ERFR I:Incoming Correspondence |
| ASSIGNED TO LIE | 2011-05-31 | 13 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2011-06-07 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2011-06-07 | 15 TEME I:Incoming Correspondence |
| EXPARTE APPEAL RECEIVED AT TTAB | 2011-06-10 | 16 EXAF T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2011-06-10 | 17 JURT T:TTAB Proceeding |
| EX PARTE APPEAL-INSTITUTED | 2011-06-10 | 18 EXPI T:TTAB Proceeding |
| ACTION CONTINUING FINAL - COMPLETED | 2011-06-27 | 19 CNCF S: |
| ACTION DENYING REQ FOR RECON MAILED | 2011-06-27 | 20 RECD O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2011-07-28 | 21 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2011-08-01 | 22 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2011-08-01 | 23 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-08-23 | 24 CNSA P: |
| EXPARTE APPEAL TERMINATED | 2011-08-23 | 25 EXPT T:TTAB Proceeding |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-08-25 | 26 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2011-09-07 | 27 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2011-09-27 | 28 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2011-11-22 | 29 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2012-05-11 | 30 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2012-05-11 | 31 EXT1 S: |
| EXTENSION 1 GRANTED | 2012-05-11 | 32 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | 2012-05-15 | 33 EXRA O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2012-11-12 | 34 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2012-11-14 | 35 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2012-11-12 | 36 EXT2 S: |
| EXTENSION 2 GRANTED | 2012-11-14 | 37 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | 2012-11-15 | 38 EXRA O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2013-05-17 | 39 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2013-05-17 | 40 EXT3 S: |
| EXTENSION 3 GRANTED | 2013-05-20 | 41 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | 2013-05-21 | 42 EXRA O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2013-05-30 | 43 TCCA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2013-10-23 | 44 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2013-10-23 | 45 EXT4 S: |
| EXTENSION 4 GRANTED | 2013-10-25 | 46 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2013-10-26 | 47 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2014-05-20 | 48 EEXT I:Incoming Correspondence |
| EXTENSION 5 FILED | 2014-05-20 | 49 EXT5 S: |
| EXTENSION 5 GRANTED | 2014-05-23 | 50 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2014-05-24 | 51 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2014-12-29 | 52 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2014-12-29 | 53 MAB6 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 KABIPAC 79038118 not registered Dead/Abandoned |
Fresenius SE & Co. KGaA 2007-03-28 |
 KABIPAC 77962974 not registered Dead/Abandoned |
Fresenius SE 2010-03-19 |
 KABIPAC 77506746 not registered Dead/Abandoned |
Fresenius Kabi AG 2008-06-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 